Bank Of America Corp Axcella Health Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.31 - $0.77 $5,059 - $12,566	16,320 Added 20923.08%	16,398 $7,000
Q4 2022 Feb 10, 2023	BUY	$0.16 - $1.1 $12 - $85	78 New	78 $0
Q1 2022 May 16, 2022	SELL	$1.58 - $2.82 $385 - $688	-244 Reduced 81.88%	54 $0
Q4 2021 Feb 08, 2022	SELL	$2.06 - $3.61 $733 - $1,285	-356 Reduced 54.43%	298 $1,000
Q3 2021 Nov 15, 2021	SELL	$2.98 - $4.31 $7,974 - $11,533	-2,676 Reduced 80.36%	654 $2,000
Q2 2021 Sep 13, 2021	BUY	$3.08 - $5.13 $10,256 - $17,082	3,330 New	3,330 $13,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.